Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 9
Original Research
Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,196 | Dovepress* | 6,333+ | 411 | 6,744 | |
| PubMed Central* | 863 | 415 | 1,278 | ||
| Totals | 7,196 | 826 | 8,022 | ||
| *Since 10 March 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar